S.MunckE.ParkM
Neuen BL, Ohkuma T, Neal B, Matthews DR, de Zeeuw D, Mahaffey KW, et al
As of early 2025, the FDA had received more than 455 adverse event reports linked to compounded semaglutide and more than 320 reports associated with compounded tirzepatide, many involving dosing errors from patients self-administering incorrect doses - some of which required hospitalization
Other Ingredients: Carbomer, microcrystalline cellulose, calcium phosphate, beet root powder (color), stearic acid (vegetable source), magnesium stearate (vegetable source), silicon dioxide and coating (hydroxypropylmethylcellulose, microcrystalline cellulose, stearic acid [vegetable source])
Thus, the exact effect of liver PPAR on drug-induced liver injury remains obscure